Cargando…

Hydroxocobalamin as a Cause of Oxalate Nephropathy

Detalles Bibliográficos
Autor principal:	Legrand, Matthieu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308826/ https://www.ncbi.nlm.nih.gov/pubmed/30596186 http://dx.doi.org/10.1016/j.ekir.2018.10.010

Ejemplares similares

Hydroxocobalamin-Induced Oxalate Nephropathy in a Patient With Smoke Inhalation
por: Evans, Jordan, et al.
Publicado: (2021)

Oxalate Nephropathy
por: Etta, Praveen K., et al.
Publicado: (2023)

The Durability of Intravenous Hydroxocobalamin in Vasoplegia
por: Blaha, Madeline, et al.
Publicado: (2023)

Acute oxalate nephropathy caused by ethylene glycol poisoning
por: Seo, Jung Woong, et al.
Publicado: (2012)

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies
por: Kletzmayr, Anna, et al.
Publicado: (2020)

Hemodialysis Complications of Hydroxocobalamin: A Case Report
por: Sutter, Mark, et al.
Publicado: (2010)

Oxalate nephropathy: a review
por: Rosenstock, Jordan L, et al.
Publicado: (2021)

A hidden cause of oxalate nephropathy: a case report
por: Mahmoud, Tala, et al.
Publicado: (2021)

Plasma Oxalate Concentration and Patients With CKD
por: Oka, Yoshinari, et al.
Publicado: (2021)

High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm
por: Cheungpasitporn, Wisit, et al.
Publicado: (2017)

Diet-induced oxalate nephropathy
por: Clark, Barbara, et al.
Publicado: (2019)

Oxalate nephropathy: An important cause of renal failure after bariatric surgery
por: Nagaraju, S. P., et al.
Publicado: (2013)

Vitamin C-Induced Oxalate Nephropathy
por: Lamarche, Jorge, et al.
Publicado: (2011)

Acute oxalate nephropathy associated with orlistat
por: Humayun, Youshay, et al.
Publicado: (2016)

The Role of Oxidative Stress and Inflammation in Acute Oxalate Nephropathy Associated With Ethylene Glycol Intoxication
por: Wilson, Gregory J., et al.
Publicado: (2018)

Hydroxocobalamin in Refractory Septic Shock: A Retrospective Case Series
por: Sacco, Alicia J., et al.
Publicado: (2021)

Extended Duration Infusion of Hydroxocobalamin for Vasoplegic Rescue in Septic Shock
por: Gerdes, Harrison J, et al.
Publicado: (2021)

High-Dose Hydroxocobalamin for Refractory Vasoplegia Post Cardiac Surgery
por: Bak, Marek A, et al.
Publicado: (2022)

Secondary Oxalate Nephropathy: A Systematic Review
por: Lumlertgul, Nuttha, et al.
Publicado: (2018)

Oxalate nephropathy: A three-dimensional view
por: Ward, Ashley, et al.
Publicado: (2015)

Acute Oxalate Nephropathy Caused by Excessive Vegetable Juicing and Concomitant Volume Depletion
por: Chaudhari, Harshad, et al.
Publicado: (2022)

Kaleidoscopic Views in the Bone Marrow: Oxalate Crystals in a Patient Presenting with Bicytopenia
por: Dere, Yelda, et al.
Publicado: (2016)

Etiologies, Clinical Features, and Outcome of Oxalate Nephropathy
por: Buysschaert, Benoit, et al.
Publicado: (2020)

Oxalate Nephropathy in an Oxalobacter formigenes–Negative Subject
por: Nazzal, Lama, et al.
Publicado: (2020)

Single-Molecule Conformational Dynamics of a Biologically Functional Hydroxocobalamin Riboswitch
por: Holmstrom, Erik D., et al.
Publicado: (2014)

Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
por: Ayasa, Laith A, et al.
Publicado: (2023)

Is urinary oxalate inversely correlated with glomerular filtration rate in chronic kidney disease?
por: Xue, Cheng, et al.
Publicado: (2019)

Association between hydroxocobalamin administration and acute kidney injury after smoke inhalation: a multicenter retrospective study
por: Dépret, François, et al.
Publicado: (2019)

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
por: Ayers, Brian, et al.
Publicado: (2020)

Efficacy of intramuscular hydroxocobalamin supplementation in cats with cobalamin deficiency and gastrointestinal disease
por: Kook, Peter H., et al.
Publicado: (2020)

High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
por: Sakpal, Sujit Vijay, et al.
Publicado: (2019)

Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19
por: Fontana, Francesco, et al.
Publicado: (2020)

A Case of Hydroxocobalamin-Induced False Blood Leak Alarm on Dialysis Machine
por: Datar, Praveen, et al.
Publicado: (2019)

Author Reply to Comment on “Assessment of Plasma Oxalate Concentration in Patients With CKD” by Oka et al.
por: Pfau, Anja, et al.
Publicado: (2021)

Loss of Ecrg4 improves calcium oxalate nephropathy
por: Cabuzu, Daniela, et al.
Publicado: (2022)

A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compressive neuralgias
por: Goldberg, Henrique, et al.
Publicado: (2017)

NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
por: Knauf, Felix, et al.
Publicado: (2013)

Oxalate nephropathy is a major cause of kidney injury in surgically treated pancreatic adenocarcinoma patients
por: Desbuissons, Geoffroy, et al.
Publicado: (2019)

Microcirculation-targeted resuscitation in septic shock: can complex problems have simple answers?
por: Joffre, Jérémie, et al.
Publicado: (2021)

Reddish‐purple effluent fluid induced by hydroxocobalamin in continuous renal replacement therapy
por: Yamamoto, Miyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mct47s7baroftahqg3m9p83jl3